Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Studies from J.R. Garbay et al have provided new data on breast cancer
January 1st, 2009
"The role of radiofrequency (RF) ablation to treat local recurrence of breast cancer is unknown. We conducted a two-stage phase II clinical trial," scientists writing in the journal Annals of Surgical Oncology report. "Eligible patients had a histologically confirmed noninflammatory and <= 3 cm ipsilateral breast tumor recurrence. The tumor site was identified by intraoperative sonography. A LeVeen needle electrode (RadioTherapeutics Corp, Mountain View, Calif) was inserted into a single site within the tumor and radiofrequency ablation was performed using a RF-2000 generator (RadioTherapeutics Corp). After completion of radiofrequency, a mastectomy was...
Source: Women's Health Weekly (2009-01-01)
|
